BOVALTO PASTOBOV

País: Irlanda

Idioma: anglès

Font: HPRA (Health Products Regulatory Authority)

ingredients actius:

MANNHEIMIA HAEMOLYTICA TYPE 1A ANTIGEN LEUCOTOXIN

Disponible des:

Merial Animal Health Limited

Codi ATC:

QI02AB04

Designació comuna internacional (DCI):

MANNHEIMIA HAEMOLYTICA TYPE 1A ANTIGEN LEUCOTOXIN

Dosis:

2 Millilitre

formulario farmacéutico:

Suspension for Injection

tipo de receta:

POM(E)

Grupo terapéutico:

Bovine

Área terapéutica:

Pasteurella vaccine

indicaciones terapéuticas:

Immunological - Inactivated vaccine

Estat d'Autorització:

Authorised

Data d'autorització:

2000-02-01

Fitxa tècnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
BOVALTO PASTOBOV
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection – Milky beige.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of cattle to reduce clinical signs and lesions of_
Mannheimia haemolytica_* A1 induced respiratory
disease.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
ACTIVE SUBSTANCE:
_Mannheimia haemolytica*_ type A1 antigen: leucotoxin minimum of
68 ELISA.U**
*_ Mannheimia haemolytica_ was formerly called_ Pasteurella
haemolytica_
** 1 ELISA.U: q.s. to obtain a_ Mannheimia haemolytica_ antibody titre
of 1 ELISA unit in mice after two
administrations of vaccine
ADJUVANT(S):
Aluminium (as hydroxide)
4.2 mg
EXCIPIENT(S):
Thiomersal
0.2 mg
Excipient
q.s.p. 1 dose of
2
ml
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_5_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_1_
_9_
_8_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS:
Shake well before use.
Apply usual aseptic procedures.
Vaccinate only healthy animals.
Apply usual procedures for the handling of the animals.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS:
In the case of accidental